Evidence map›Paper›PMID 36180083›Full record

ArticleThe European respiratory journal2022

Impact of the COVID-19 pandemic on influenza and respiratory syncytial virus antibody titres in the community: a prospective cohort study in Neustadt, Thuringia, Germany.

Mathias W Pletz, Ralf Dürrwald, Janine Reiche, Norman Rose, André Scherag, Sebastian Weis, CoNAN study group

Open access · hybridAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The European respiratory journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Impact of COVID-19 Nonpharmaceutical Interventions onOpen forum infectious diseases · 2024
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mathias W PletzInstitute of Infectious Diseases and Infection Control, Jena University Hospital-Friedrich Schiller University, Jena, Germany mathias.pletz@med.uni-jena.de.ORCID 0000-0001-8157-2753
Ralf DürrwaldDepartment of Infectious Diseases, Unit 17, Influenza and Other Respiratory Viruses, National Influenza Centre and Consultant Laboratory for RSV, PIV and HMPV, Robert Koch Institute, Berlin, Germany.ORCID 0000-0002-3432-0438
Janine ReicheDepartment of Infectious Diseases, Unit 17, Influenza and Other Respiratory Viruses, National Influenza Centre and Consultant Laboratory for RSV, PIV and HMPV, Robert Koch Institute, Berlin, Germany.
Norman RoseInstitute of Infectious Diseases and Infection Control, Jena University Hospital-Friedrich Schiller University, Jena, Germany.
André ScheragCenter for Sepsis Care and Control (CSCC), Jena University Hospital-Friedrich Schiller University, Jena, Germany.
Sebastian WeisInstitute of Infectious Diseases and Infection Control, Jena University Hospital-Friedrich Schiller University, Jena, Germany.
CoNAN study group
Jena University Hospital · DERobert Koch Institute · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Influenza, HumanRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsAntibodies, ViralHumansPandemicsProspective StudiesRespiratory Syncytial VirusesAntibodies, Viral

Identifiers

PMID36180083
PMCPMC9647071
OpenAlexW4298140440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.